Work

Treatment Effects of Alirocumab as an Add-on to Maximally Tolerated Dose of Statin in Patients With Heterozygous Familial Hypercholesterolemia And/or Atherosclerotic Cardiovascular Disease

Year: 2017

Type: article

Source: Journal of the American College of Cardiology

DOI: 10.1016/s0735-1097(17)33543-x

Authors: Robert J. Weiss, Seth Baum, Dirk Blom, Jean Bergeron, Gisle Langslet, Santosh Sanganalmath, Julia Yang, Jonas Mandel, Prediman Shah

Institutions: Regeneron (United States), Sanofi (France)

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2596275816

FWCI:

Cites:

Cited by:

Related to: 10